Something is happening in kitchens, gyms, and pharmacy queues that the support system around health has not caught up with. Millions of people are now taking a class of medication that changes, at the level of biological signaling, how hungry they feel. Semaglutide, liraglutide, and tirzepatide, the last of which is sold under the brand name Mounjaro, act on the incretin system. They slow the rate at which the stomach empties. They quiet the part of the appetite conversation that used to run all day, every day, for years.
For a great many people this is the first intervention in a long personal history of attempts that has actually worked. That deserves to be said plainly and without hedging. It also deserves to be said that the medication answers exactly one question, and that there are three more waiting behind it.
The medication answers the appetite question. It does not answer what your body will be built out of at the end of the process. It does not answer what your relationship with food becomes when hunger stops arriving on schedule. And it does not answer what happens when the medication stops. Those three questions are where most people are currently on their own, and they are what this piece is about.
Before going further, a boundary that matters. Nothing here is medical advice, and nothing here should change how you take a medication a prescriber has given you. Dosing, timing, missed doses, side effect management, and the decision to start, continue, or stop belong to the clinician who prescribed it and to the pharmacist who dispenses it. What follows is context about the territory that sits alongside the prescription, and about the people who can help you cover it.
What the medication does, and what it does not do
The most persistent misunderstanding about this class of drug is that it burns fat. It does not. There is no metabolic furnace being switched on.
What happens is closer to a volume control. These medications mimic gut hormones that your body already produces after eating, which reduces appetite signaling in the brain and slows gastric emptying so that food stays in the stomach longer. The practical result is that you feel full sooner, stay full longer, and think about food less. Weight comes off because intake falls, not because the drug metabolizes anything on your behalf.
This distinction is not academic. It explains why some people plateau despite perfect adherence, and it explains why the food you do eat carries far more weight, so to speak, than it used to. When total intake drops sharply, every meal has to do more work. There is simply less room for anything that is not pulling its weight nutritionally.
It also explains the most common frustration people report. If your portions have not changed, because eating is a habit as much as a hunger response and habit does not always follow appetite, the deficit that drives weight loss may never open up. The medication makes eating less easy. It does not make it automatic.
Roughly a quarter of what you lose is not fat
This is the number that almost nobody is told at the point of prescription, and it is the number that should shape everything else.
In a substudy of the SURMOUNT-1 trial, 160 participants had body composition measured by DXA scan at baseline and again at 72 weeks. Body weight fell by 21.3 percent. Fat mass fell by 33.9 percent. Lean mass fell by 10.9 percent. Of the total weight lost, approximately 75 percent was fat and approximately 25 percent was lean tissue.
That finding has held up across the wider literature. A network meta-analysis of 22 randomized trials found lean mass loss comprising roughly a quarter of total weight loss across this drug class, with tirzepatide and semaglutide the most effective for total weight reduction and among the least effective at preserving lean tissue. A 2026 systematic review published in the Annals of Internal Medicine, covering 35 trials, found a median of 28.3 percent of weight lost attributable to reductions in muscle related tissue, exceeding the prespecified benchmark in about two thirds of the studies examined.
Here is the part that changes how you should read all of it. In the SURMOUNT-1 substudy, that same 75 to 25 split appeared in the placebo group. A 2026 meta-analysis of 20 trials covering 15,782 participants put tirzepatide at 25.4 percent of weight lost as lean mass and intensive lifestyle intervention at 26.2 percent, a difference that was not statistically significant.
So this is not a drug problem. It is a weight loss problem. Any substantial reduction in body weight, achieved by any means, takes lean tissue with it unless something is actively done to prevent that.
In that same 2026 analysis, one condition stood apart. Lifestyle intervention combined with resistance training produced lean mass loss of 17.5 percent of total weight lost, against 25 to 39 percent everywhere else. That is the intervention with the evidence behind it, and it is almost never on the prescription.
Why the ratio matters more than the number on the scale
It is tempting to treat lean mass as an abstraction, a line on a scan that has no bearing on a Tuesday. It is not.
A narrative review published in Diabetes Care put the scale of it in terms that are hard to unsee. Incretin therapies producing 15 to 24 percent weight loss are associated with lean mass losses in the region of 10 percent, or roughly six kilograms, which the authors compared to a decade or more of normal aging. Muscle is what carries you up a flight of stairs at 70. Its loss is tightly linked to frailty, to falls, and to the loss of independence.
The same review noted what supervised resistance training can do in the other direction: programs running longer than ten weeks have produced increases in lean mass of around three kilograms and strength gains of around 25 percent in both men and women. Recent trial work has gone further still, testing pharmaceutical approaches to preserving muscle during treatment, which tells you how seriously the field now takes this.
None of that requires a gym membership or an athletic history. It requires progressive resistance work, two or three times a week, supervised by someone who knows how to program it for a body that is currently in a large energy deficit. That is a real skill and it is worth paying for.
And then there is the stopping problem
The SURMOUNT-4 trial was designed to answer a question people ask constantly and get vague answers to. Participants took tirzepatide for 36 weeks and lost a mean of 20.9 percent of body weight. They were then randomized either to continue or to switch to placebo for a further 52 weeks.
Those who continued lost a further 5.5 percent. Those who switched to placebo regained 14 percent. At the end of the study, 89.5 percent of those still on treatment had maintained at least 80 percent of their weight loss. Among those who had stopped, 16.6 percent had.
A 2026 review synthesizing withdrawal trials and real world cohorts covering more than 289,000 patients described weight regain of 60 to 90 percent within a year of discontinuation, with cardiometabolic improvements reversing in parallel. The authors argued that stopping should be treated as a high risk clinical transition rather than a finish line. More recent trial work has tested dose reduction as an alternative to stopping outright, with meaningfully better maintenance than placebo, which is a conversation to have with a prescriber rather than a decision to make alone.
Read that alongside the lean mass data and the implication is uncomfortable but clarifying. If a meaningful share of what you lost was muscle, and if most of the weight comes back when treatment ends, then the version of your body that exists after all of this depends heavily on what you built while the medication was doing the appetite work for you.
The strength you gain is yours. The cooking you learn is yours. The sleep and the movement and the changed relationship with food are yours. The appetite suppression is rented.
The appetite paradox
Appetite suppression is the mechanism, and it is also the risk.
When food stops feeling urgent, it becomes remarkably easy to eat far too little, and specifically to eat too little of the things that are hardest to fit into small volumes. Protein is the obvious one. Fiber, which matters for the constipation that many people experience, is another. Micronutrients quietly go the same way. Add nausea, reflux, and early fullness to the picture and you have a set of conditions in which undereating is not a failure of willpower but the path of least resistance.
The figure most commonly cited for protein during weight loss sits somewhere between 1.2 and 1.6 grams per kilogram of body weight per day, higher than the general population guideline of 0.8. That is a reasonable starting point for a conversation, and it is not a prescription you should write for yourself.
The evidence here is also more nuanced than the internet suggests. In a randomized controlled trial of 100 adults aged 55 to 80 on a ten week weight loss program, a higher protein diet on its own did not significantly preserve fat free mass. Only the group combining higher protein with resistance exercise showed a significant increase. A separate trial in postmenopausal women reached a similar conclusion: higher protein without exercise did not preserve fat free mass or resting energy expenditure, though it appeared to help maintain muscle strength.
The takeaway is not that protein does not matter. It is that protein is necessary and, on its own, not sufficient. Protein plus resistance training is the combination that has repeatedly worked. Protein alone is half a strategy, and it is the half that gets all the coverage.
This is exactly the kind of question that a registered dietitian earns their fee on, because the answer depends on your body weight, your baseline, your kidney function, your medication, and what you can actually keep down on a bad week.
The things that do not show up in a trial endpoint
Clinical trials measure weight, body composition, and biomarkers. They do not measure what people actually talk about.
Food is social infrastructure. It is how families mark occasions and how friendships get maintained. When your capacity for it shrinks by two thirds, a lot of ordinary life quietly reorganizes itself, and people are often surprised by how much they grieve something they spent years trying to control.
There is an identity dimension too. Losing a significant amount of weight changes how strangers treat you, and that is not uniformly pleasant. Body image frequently lags the physical change by a long way. Loose skin, changes in hair, and fatigue all arrive without warning.
And there is the anxiety about stopping, which the trial data does nothing to soothe. People on these medications frequently describe a low background dread about what happens if supply is interrupted, if the cost becomes unmanageable, or if a prescriber changes their mind.
None of this is treated by an injection. All of it is treatable by people.
What a well constructed support team looks like
The useful mental model is not alternative versus conventional. It is coverage. There are several distinct jobs to be done and one clinician cannot do all of them.
The prescriber owns the medication. Dose, titration, side effects, interactions, monitoring, and the decision about how long to continue. Nobody else touches this. Not a coach, not a nutritionist, not a wellness practitioner, not a forum.
A registered dietitian or a qualified nutrition professional owns intake. Protein targets, texture and timing strategies when eating is uncomfortable, fiber, hydration, micronutrient adequacy, and the practical problem of getting enough nutrition into a very small appetite. Look for a recognized professional registration in your country and ask directly whether they have worked with clients on incretin therapy.
A strength coach or physiotherapist owns the training. Progressive resistance work, appropriately programmed for someone in an energy deficit, with attention to fatigue and joint load. Ask how they would structure the first twelve weeks and what they would measure. If the answer is only cardio, keep looking.
Someone owns the psychological side. A counselor, psychotherapist, or a practitioner working in the food relationship space. This is the part people skip and later say they wish they had not.
Around that core, a range of complementary practitioners can genuinely help with the surrounding experience. Sleep support, stress and nervous system regulation, gentle movement practices for people returning to activity after years away, body work for the muscular tension and postural change that comes with a rapidly changing body. These are not treatments for obesity and no honest practitioner will present them as such. They are support for a person going through something demanding, and framed that way they have real value.
How to tell a good practitioner from a bad one
The bar is not complicated. Ask what they treat and see whether the answer is a practice or a promise.
Walk away from anyone who suggests reducing or stopping a prescribed medication. Walk away from anyone selling a supplement, protocol, or program positioned as a natural alternative to what your prescriber gave you. Walk away from anyone offering to detox, clear, or counteract the medication, which is not a thing. Walk away from anyone who will not put in writing that they work alongside your medical team rather than instead of it.
Then look for the opposite signals. A practitioner who asks what you are taking and who prescribes it. One who is specific about what their practice does and equally specific about what it does not. One who refers out when something is beyond their scope. One who is registered with a recognized professional body and can tell you which one without hesitating.
Trustworthiness in this field is not mysterious. It is mostly a willingness to name limits.
When to stop reading and call someone
Some symptoms are not a wellness question. Contact your prescriber, an out of hours service, or emergency services if you experience severe or worsening abdominal pain, particularly pain that radiates through to your back. The same applies to vomiting that persists for many hours, or any situation in which you cannot keep fluids down.
No practitioner outside a clinical setting should be managing those symptoms, and any who offers to is telling you something important about their judgment.
The argument, stated plainly
The medication is a genuine advance and the people taking it do not need to be lectured about it. But a prescription is a narrow instrument. It handles appetite with real precision and it hands everything else back to the patient, usually with a leaflet.
Everything else is substantial. It is roughly a quarter of your weight loss coming out of muscle unless you train. It is a nutritional problem that gets harder as intake falls. It is a relationship with food that has to be rebuilt rather than merely suppressed. It is a rebound curve waiting at the end of treatment that only accumulated habit can flatten.
The honest position is that this work is not optional and it is not solitary. It needs a prescriber, a nutrition professional, someone who knows how to make you stronger, and usually someone to talk to. Finding those people should not be the hardest part of the process. At the moment, for most people, it is.
Common questions
Is there an official diet for these medications? No. There is no manufacturer approved or clinically mandated eating plan, and any source presenting a fixed seven day menu as the plan is inventing authority it does not have. What the evidence supports is adequate protein, sufficient fiber, adequate hydration, and enough total intake to avoid deficiency. Turning that into meals that suit your appetite, your tolerance, and your life is what a dietitian is for.
How much protein should I be eating? The range most commonly used in the research on weight loss is 1.2 to 1.6 grams per kilogram of body weight per day, against a general guideline of 0.8. Whether that range is right for you depends on your weight, your kidney function, your other conditions, and what you can realistically tolerate. Bring the number to a qualified professional rather than adopting it from an article, including this one.
What happens if I do not get enough protein? During substantial weight loss the body draws on lean tissue as well as fat. Insufficient protein intake, particularly without resistance training, is associated with greater loss of fat free mass. Fatigue and reduced strength are the effects people notice first. If eating enough is proving difficult, that is a reason to get support rather than a reason to accept it.
Are protein shakes a reasonable option? Many people find liquid protein easier to tolerate when appetite is low or chewing a full meal feels like too much. Whether a supplement suits you, and which one, is a question for a pharmacist or dietitian who can see your full medication list. Whole food sources remain the sensible foundation where you can manage them.
Will I lose weight if I keep eating the way I always have? Only if the way you always ate happens to now sit below your energy requirement. The medication reduces hunger. It does not reduce the calories in food you eat out of habit rather than appetite. Many people find the honest answer emerges only when they pay attention to what they are actually eating rather than what they feel like eating.
How much weight is realistic in a week? Weekly figures are a poor way to think about this. Body weight moves with fluid, glycogen, and digestion, so a large drop in a single week is rarely all fat and a flat week is rarely a failure. Trials measure change over months for good reason. If your rate of loss concerns you in either direction, that is a conversation for your prescriber.
What should I do if I have eaten too much and feel unwell? Because these medications slow gastric emptying, a large or fatty meal can sit uncomfortably for a long time. General comfort measures are unremarkable: sipping fluids, plain low fat food, and returning to your normal pattern at the next meal rather than skipping it. The exceptions are the ones listed above. Severe pain, particularly radiating to the back, or vomiting you cannot stop, are reasons to seek medical help rather than wait it out.
Can a complementary practitioner help me while I am on this medication? For the surrounding experience, frequently yes. Sleep, stress, movement, and the psychological side of a rapidly changing body are all areas where good practitioners do real work. For the medication itself and for anything that looks like a medical symptom, no. Any practitioner who blurs that line is one to avoid.
Sources
- •Look M et al. Body composition changes during weight reduction with tirzepatide in the SURMOUNT-1 study of adults with obesity or overweight. Diabetes, Obesity and Metabolism, 2025.
- •Karakasis P et al. Effect of glucagon-like peptide-1 receptor agonists and co-agonists on body composition: systematic review and network meta-analysis. Metabolism, 2024.
- •Eisa N et al. Lean mass changes with incretin therapy versus lifestyle intervention: a systematic review and meta-analysis of randomised controlled trials. Diabetes, Obesity and Metabolism, 2026.
- •Batsis J et al. Effect of incretin-based and nonpharmacologic weight loss on body composition: a systematic review. Annals of Internal Medicine, 2026.
- •Locatelli JC et al. Incretin-based weight loss pharmacotherapy: can resistance exercise optimize changes in body composition? Diabetes Care, 2024.
- •Aronne L et al. Continued treatment with tirzepatide for maintenance of weight reduction in adults with obesity: the SURMOUNT-4 randomized clinical trial. JAMA, 2023.
- •Shah E et al. Clinical management of weight regain and cardiometabolic consequences after discontinuation of GLP-1 receptor agonists. Diabetes, Obesity and Metabolism, 2026.
- •Horn DB et al. Tirzepatide for maintenance of bodyweight reduction in people with obesity in the USA (SURMOUNT-MAINTAIN). The Lancet, 2026.
- •Verreijen A et al. Effect of a high protein diet and/or resistance exercise on the preservation of fat free mass during weight loss in overweight and obese older adults. Nutrition Journal, 2017.
- •Englert I et al. Impact of protein intake during weight loss on preservation of fat-free mass, resting energy expenditure, and physical function in overweight postmenopausal women. Obesity Facts, 2021.
This article is general information about a widely discussed area of health. It is not medical advice, it is not a treatment recommendation, and it is not a substitute for the judgment of the clinician who prescribed your medication. Always speak to your prescriber before changing anything about your treatment.
